This image summarises the increased risk that the presence of depressive symptoms confers on an individual for developing a variety of comorbid conditions. Many of these relationships are thought to be bidirectional – i.e., one increases the chances of the other and vice versa – and this complexity reinforces the need for integrated models of care that take into account the patient as a whole.
MDD=major depressive disorder
Related content
Treatment-resistant depression (TRD) represents a significant clinical challenge, affecting approximately 30% of individuals with major depressive disorder (MDD) who fail to respond to at least two adequate antidepressant trials.
Sequential treatment optimization scheme for major depressive disorder generated according to international evidence.
Key steps for managing factors that may confound antidepressant treatment response, including dose, side effects, comorbidities, stressors, adherence, pharmacogenomics, interactions, and treatment algorithms.